Senate Seeks to Reduce Biosimilar Prices by Pruning Patent Thickets
Written by : Susan M. Janicki, Ph.D. & Eric Furman, Ph.D. On July 10, the Senate unanimously passed the Affordable Prescriptions for Patients Act of 2023 (S.150), which seeks to increase competition and lower drug prices by imposing limits on patent…